Palvella Therapeutics PVLA
NASDAQ PVLA
$126.29 -0.29 (-0.23%)
As of: Oct 22, 2026 · 11:02 AM EDT

Palvella Therapeutics (PVLA) Long-Term Debt Repayments (2015)

Updated

Palvella Therapeutics' Long-Term Debt Repayments came in at $1.16 million for FY2015, up 537.9% from $181,515 in FY2014.

Analysis

Palvella Therapeutics (PVLA) Long-Term Debt Repayments (2015) Analysis & Trends

  • Per Business Quant, earlier years put Long-Term Debt Repayments at $181,515 in FY2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,171.06 Bn 1,139.65 Bn 19.71 Bn 873.00 Mn
2 Johnson & Johnson 634.89 Bn 553.42 Bn 17.26 Bn 1.00 Mn
3 AbbVie 503.32 Bn 476.44 Bn 12.70 Bn 2.00 Bn
4 Merck 377.44 Bn 331.82 Bn 12.21 Bn 5.00 Mn
5 Novartis Ag 303.91 Bn 267.90 Bn 11.24 Bn 20.00 Mn
6 Astrazeneca 267.03 Bn 240.72 Bn 12.86 Bn 2.46 Bn
7 Amgen 241.88 Bn 197.28 Bn 7.24 Bn -
8 Gilead Sciences 194.01 Bn 168.20 Bn 6.22 Bn 17.00 Mn
9 Pfizer 172.57 Bn 119.21 Bn 10.94 Bn -
10 Palvella Therapeutics 1.82 Bn 1.57 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2015 -13,230.00
Jun 30, 2015 43,365.00
Mar 31, 2015 1.13 Mn
API Access

Palvella Therapeutics Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=PVLA&period=max&api_key=YOUR_API_KEY